- Database
- November 2023
Global
From €21442EUR$24,500USD£18,639GBP
- Database
- November 2023
Spain
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
Japan
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
Italy
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
Germany
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
France
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
United States, Europe, ... United States, Europe, Global
From €15316EUR$17,500USD£13,314GBP
- Database
- November 2023
Middle East
From €3938EUR$4,500USD£3,423GBP
- Database
- November 2023
Latin America
From €8314EUR$9,500USD£7,227GBP
- Database
- November 2023
Europe
From €15316EUR$17,500USD£13,314GBP
- Database
- November 2023
United States
From €2407EUR$2,750USD£2,092GBP
- Database
- November 2023
United Kingdom
From €2144EUR$2,450USD£1,864GBP
- Database
- November 2023
Nicaragua
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Vietnam
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Venezuela
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Switzerland
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Sweden
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
South Korea
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Slovenia
From €1269EUR$1,450USD£1,103GBP
- Database
- November 2023
Slovakia
From €1269EUR$1,450USD£1,103GBP

The Mycoplasma market within the context of Diagnostics is a rapidly growing sector. Mycoplasma are a type of bacteria that can cause a range of diseases in humans and animals. Diagnostic tests for Mycoplasma are used to detect the presence of the bacteria in a patient's sample. These tests are used to diagnose and monitor the progression of Mycoplasma-related diseases, as well as to monitor the effectiveness of treatments.
Mycoplasma diagnostic tests are used in a variety of settings, including clinical laboratories, research laboratories, and veterinary clinics. The tests are available in a variety of formats, including ELISA, PCR, and culture-based assays.
The Mycoplasma diagnostic market is expected to continue to grow in the coming years, driven by the increasing prevalence of Mycoplasma-related diseases, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnostic tests.
Some of the major companies in the Mycoplasma diagnostic market include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, Becton Dickinson, and Roche Diagnostics. Show Less Read more